Term Name: leukotriene B4
Synonyms: (5S,12R,6Z,8E,10E,14Z)-5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid, (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyeicosa-6,8,10,14-tetraenoic acid, (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid, (S-(R*,S*-(E,Z,E,Z)))-5,12-Dihydroxy-6,8,10,14-eicosatetraenoic acid, 5(S),12(R)-dihydroxy-6(Z),8(E),10(E),14(Z)-eicosatetraenoic acid, 5(S),12(R)-dihydroxy-6(Z),8(E),10(E),14(Z)-icosatetraenoic acid, 5,12-Dihete, 5,12-Hete, 5S,12R-diHETE, 5S,12R-dihydroxy-6Z,8E,10E,14Z-eicosatetraenoic acid, Leukotriene B4, LTB4
Definition: A leukotriene composed of (6Z,8E,10E,14Z)-icosatetraenoic acid having (5S)- and (12R)-hydroxy substituents. It is a lipid mediator of inflammation that is generated from arachidonic acid via the 5-lipoxygenase pathway.
Ontology: ChEBI [CHEBI:15647]  ( EBI )

Relationships
is a type of: dihydroxy monocarboxylic acid hydroxy polyunsaturated fatty acid leukotriene long-chain fatty acid
has_functional_parent: icosa-6,8,10,14-tetraenoic acid
has_role: human metabolite mouse metabolite plant metabolite vasoconstrictor agent
inverse has_functional_parent: 10,11-dihydro-12-oxoleukotriene B4 10,11-dihydro-20,20,20-trihydroxyleukotriene B4 10,11-dihydro-20,20-dihydroxyleukotriene B4 12,20-dioxoleukotriene B4 12-dehydro-leukotriene B4 12-oxo-20-hydroxyleukotriene B4 18-hydroxy-18-oxo-dinorleukotriene B4 18-hydroxyleukotriene B4 19-hydroxyleukotriene B4 20,20,20-trihydroxyleukotriene B4 20,20-dihydroxyleukotriene B4 20-hydroxy-20-oxoleukotriene B4 20-hydroxy-leukotriene B4
inverse is_conjugate_base_of: leukotriene B4(1-)
is_conjugate_acid_of: leukotriene B4(1-)